Related Experiment Video

Updated: Apr 12, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.8K

[Cutaneous malignant melanoma and the new drugs]

Omgo E Nieweg1, José Francisco Gallegos-Hernández2

  • 1Melanoma Institute Australia.

Cirugia Y Cirujanos
|May 24, 2015
PubMed

Insights

Recent advances in targeted therapy and immunotherapy offer new systemic treatment options for cutaneous melanoma, complementing established surgical approaches. These novel drugs provide alternatives for patients with tumor progression or distant metastasis.

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Context:

  • Cutaneous melanoma treatment has historically relied on surgery, with established resection margins and lymphadenectomy criteria.
  • Systemic treatment options for advanced cutaneous melanoma have seen limited progress since the introduction of dacarbazine in the 1970s.

Purpose:

  • To review the evolving role of surgery in cutaneous melanoma management.
  • To elucidate the mechanisms of action for newly introduced targeted therapy and immunotherapy drugs.
  • To present emerging therapeutic alternatives for cutaneous melanoma based on scientific evidence.

Summary:

  • While surgery remains crucial for cutaneous melanoma, systemic treatments have lagged until recently.
  • Dacarbazine, used since the 1970s for advanced disease, has shown disappointing results.
  • New targeted therapy and immunotherapy drugs, introduced in the last three years, offer improved outcomes and alternatives for advanced cutaneous melanoma.

Impact:

  • Highlights the significant advancements in systemic treatment for cutaneous melanoma.
  • Provides a comprehensive overview of current and emerging therapeutic strategies.
  • Informs clinicians about novel treatment options and their potential impact on patient outcomes.
Keywords:
MelanomaMelanoma treatmentTratamiento de melanoma

More Related Videos

A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.4K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
56.0K